Date: Jan 24, 2024 12:00 PM - 01:30 PM
Fee
$0.00
CE Hours
1.50
CE Units
0.150
Registration closes on Jan 31, 2024 10:00 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Registration Closed
Registration Closed
Objectives
- Describe the basic structure, function, epidemiology and clinical disease of the novel coronavirus (SARS Co-V2).
- Identify the clinical rationale and use of Anticoagulants, Anti-inflammatory, Antiviral, and Immunologic Agents in management of COVID-19 infections.
- Provide an update on oral antiviral agents for treatment of mild-to-moderate COVID-19.
- Describe any major considerations for the use of evidence-based therapies for COVID-19 management in HIV co-infected people.
- Outline candidate drug treatments for long COVID-19.
- Describe the role of pharmacists in the management of patients with COVID-19.
Speaker(s)/Author(s)
Mandana Eimen, PharmD
|
Activity Number
0010-9999-24-001-L01-P
Date:
01/24/24
Time:
12:00 PM - 01:30 PM
CE Hours
1.50
Registration Closed